Self-reported prostate cancer screening in Austria

Abstract

Objectives: The prevalence of self-reported participation and frequency of prostate cancer screening (digital rectal examination (DRE), prostate-specific antigen (PSA)) in Austrian men aged 40–79 years in the year 2005 is reported. Methods: In a population-based cross-sectional study, a representative sample of 500 men was asked whether they ever had heard of early detection of prostate cancer by DRE or PSA test and, if so, whether they had ever had a prostate cancer screening test during their life, and if so the number of tests and the type of physician. Results: Overall, the prevalence of self-reported prostate cancer screening was 55.8% (23.7% DRE only). The highest prevalence was observed in the age group of 60–69 years with 68.8% (28.1% DRE only). The highest prevalence of PSA tests was observed in the age group 70–79 years (40.9%). About 75% of the screening tests were performed by urologists. Conclusions: More than half of the target population (men aged 40–79 years) have had at least one prostate cancer screening test. Nearly one-third of men have already had one or more PSA tests. One-fifth of the PSA tests were requested by general practitioners or internists.